Cargando…
Current trends in the cardiovascular clinical trial arena (I)
The existence of effective therapies for most cardiovascular disease states, coupled with increased requirements that potential benefits of new drugs be evaluated on clinical rather than surrogate endpoints, makes it increasingly difficult to substantiate any incremental improvements in efficacy tha...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC437651/ https://www.ncbi.nlm.nih.gov/pubmed/15180910 http://dx.doi.org/10.1186/1468-6708-5-4 |